| # | Drug | Count |
|---|---|---|
| 0 | TIRZEPATIDE | 591 |
| 1 | ETANERCEPT | 491 |
| 2 | ADALIMUMAB | 344 |
| 3 | METHOTREXATE SODIUM | 169 |
| 4 | DUPILUMAB | 158 |
| 5 | METHOTREXATE | 156 |
| 6 | PREDNISONE | 112 |
| 7 | TOCILIZUMAB | 110 |
| 8 | METFORMIN | 83 |
| 9 | ERGOCALCIFEROL | 81 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | ACETAMINOPHEN, CAFFEINE, PYRILAMINE MALEATE | 4 | 0.0267 |
| 1 | INCOBOTULINUMTOXINA | 47 | 0.0081 |
| 2 | SODIUM CITRATE | 5 | 0.0040 |
| 3 | ANAKINRA | 66 | 0.0039 |
| 4 | ADALIMUMAB-RYVK | 4 | 0.0037 |
| 5 | TIRZEPATIDE | 591 | 0.0033 |
| 6 | FREMANEZUMAB-VFRM | 35 | 0.0030 |
| 7 | ERGOCALCIFEROL | 81 | 0.0027 |
| 8 | OCTREOTIDE ACETATE | 68 | 0.0022 |
| 9 | IXEKIZUMAB | 77 | 0.0021 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Interleukin-5 Antagonist [EPC] | 8 | 0.0116 |
| 1 | Interleukin-1 Receptor Antagonist [EPC] | 66 | 0.0039 |
| 2 | PCSK9 Inhibitor [EPC] | 88 | 0.0034 |
| 3 | Interleukin-17A Antagonist [EPC] | 102 | 0.0027 |
| 4 | Provitamin D2 Compound [EPC] | 81 | 0.0027 |
| 5 | Tissue-nonspecific Alkaline Phosphatase [EPC] | 21 | 0.0020 |
| 6 | CD4-directed Blocking Antibody [EPC] | 1 | 0.0019 |
| 7 | Cytolytic Agent [EPC] | 4 | 0.0017 |
| 8 | GLP-1 Receptor Agonist [EPC] | 728 | 0.0016 |
| 9 | Serotonin-4 Receptor Agonist [EPC] | 1 | 0.0015 |